Patents Assigned to Galderma R&D
  • Patent number: 9643759
    Abstract: A closure for a container including a base having a passageway extending therethrough. At least a portion of the base is configured to attach to at least a portion of an opening of a container such that the passageway is in registry with at least a portion of the opening. A cap is movably attached to the base. The cap is movable between a first position in which at least a portion of the cap blocks at least a portion of the passageway and a second position in which the cap is spaced-apart from at least a portion of the passageway to allow contents from within the container to pass therethrough. A seal is positioned on one of the cap and the base.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: May 9, 2017
    Assignee: Galderma R&D
    Inventor: Sebastien Fily
  • Publication number: 20140185964
    Abstract: A closure for a container including a base having a passageway extending therethrough. At least a portion of the base is configured to attach to at least a portion of an opening of a container such that the passageway is in registry with at least a portion of the opening. A cap is movably attached to the base. The cap is movable between a first position in which at least a portion of the cap blocks at least a portion of the passageway and a second position in which the cap is spaced-apart from at least a portion of the passageway to allow contents from within the container to pass therethrough. A seal is positioned on one of the cap and the base.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 3, 2014
    Applicant: GALDERMA R&D
    Inventor: Sebastien FILY
  • Publication number: 20140183223
    Abstract: A combination includes a child-resistant package and a collapsible tube removably positionable therein. A sidewall of a body of the package has an interior surface and an opposing exterior surface. A cavity is defined by the body. An opening is positioned proximate an open first end of the body. A bottom wall is positioned proximate an open second end of the body. A cap is removably mounted onto at least a portion of the first end of the body. The collapsible tube is surrounded by the body, the bottom wall and the cap when the cap is mounted onto at least a portion of the first end of the body. The collapsible tube includes a generally flexible housing defining a cavity for holding a substance to be dispensed from the housing. A closure is removably mounted onto the housing.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 3, 2014
    Applicant: GALDERMA R&D
    Inventor: Sebastien FILY
  • Publication number: 20140183226
    Abstract: A combination includes a container having a body with a first end and a second end. The body defines a cavity for holding contents to be dispensed from the container. An actuator is positioned proximate to the first end of the body. The actuator is operatively connected to the cavity to allow the contents to be dispensed therefrom. At least two diametrically opposed first fastening members are positioned on or in the body. A device has a generally open first end, a generally open second end, and a sidewall extending therebetween. The device is removably mountable onto the body of the container. At least two diametrically opposed second fastening members are positioned on or in an interior surface of the sidewall. Each second fastening member engages at least a portion of one of the first fastening members of the container when the device is mounted onto the container.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 3, 2014
    Applicant: GALDERMA R&D
    Inventor: Sebastien FILY
  • Publication number: 20120101141
    Abstract: Improved topical gel compositions for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
    Type: Application
    Filed: September 22, 2011
    Publication date: April 26, 2012
    Applicant: GALDERMA R&D SNC.
    Inventors: Jean-Christophe BUGE, Karine NADAU-FOURCADE, Cyril MEUNIER
  • Patent number: 8163725
    Abstract: Improved topical gel compositions for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: April 24, 2012
    Assignee: Galderma R&D SNC
    Inventors: Jean-Christophe Buge, Karine Nadau-Fourcade, Cyril Meunier
  • Publication number: 20110286944
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: November 24, 2011
    Applicant: GALDERMA R&D INC.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-Sang LIU, Matthew J. LEONI
  • Patent number: 8053427
    Abstract: Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: November 8, 2011
    Assignee: Galderma R&D SNC
    Inventors: Jean-Christophe Buge, Karine Nadau-Fourcade, Cyril Meunier
  • Publication number: 20090227668
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: May 19, 2009
    Publication date: September 10, 2009
    Applicant: Galderma R&D
    Inventors: VINCENT MANETTA, GARY R. WATKINS
  • Patent number: D727727
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: April 28, 2015
    Assignee: Galderma R&D
    Inventor: Sebastien Fily
  • Patent number: D734153
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: July 14, 2015
    Assignee: Galderma R&D
    Inventor: Sebastien Fily